MDxHealth (MDXH) Competitors $2.70 -0.05 (-1.82%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$2.78 +0.09 (+3.15%) As of 05:43 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MDXH vs. TALK, BFLY, TBRG, OM, NYXH, HCAT, SOPH, ZEPP, KRMD, and EUDAShould you be buying MDxHealth stock or one of its competitors? The main competitors of MDxHealth include Talkspace (TALK), Butterfly Network (BFLY), TruBridge (TBRG), Outset Medical (OM), Nyxoah (NYXH), Health Catalyst (HCAT), SOPHiA GENETICS (SOPH), Zepp Health (ZEPP), KORU Medical Systems (KRMD), and EUDA Health (EUDA). These companies are all part of the "medical info sys" industry. MDxHealth vs. Its Competitors Talkspace Butterfly Network TruBridge Outset Medical Nyxoah Health Catalyst SOPHiA GENETICS Zepp Health KORU Medical Systems EUDA Health Talkspace (NASDAQ:TALK) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends. Is TALK or MDXH more profitable? Talkspace has a net margin of 1.41% compared to MDxHealth's net margin of -34.98%. Talkspace's return on equity of 2.47% beat MDxHealth's return on equity.Company Net Margins Return on Equity Return on Assets Talkspace1.41% 2.47% 2.09% MDxHealth -34.98%-274.67%-21.21% Do analysts recommend TALK or MDXH? Talkspace presently has a consensus price target of $4.50, indicating a potential upside of 82.19%. MDxHealth has a consensus price target of $7.00, indicating a potential upside of 159.26%. Given MDxHealth's higher possible upside, analysts clearly believe MDxHealth is more favorable than Talkspace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Talkspace 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.00MDxHealth 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, TALK or MDXH? Talkspace has a beta of 1.06, indicating that its stock price is 6% more volatile than the S&P 500. Comparatively, MDxHealth has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500. Does the media prefer TALK or MDXH? In the previous week, Talkspace had 10 more articles in the media than MDxHealth. MarketBeat recorded 15 mentions for Talkspace and 5 mentions for MDxHealth. Talkspace's average media sentiment score of 0.32 beat MDxHealth's score of -0.75 indicating that Talkspace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Talkspace 3 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral MDxHealth 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Negative Which has better valuation & earnings, TALK or MDXH? Talkspace has higher revenue and earnings than MDxHealth. MDxHealth is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTalkspace$187.59M2.20$1.15M$0.02123.50MDxHealth$94.51M1.35-$38.07M-$0.88-3.07 Do insiders and institutionals believe in TALK or MDXH? 57.4% of Talkspace shares are owned by institutional investors. 23.5% of Talkspace shares are owned by insiders. Comparatively, 1.7% of MDxHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryTalkspace beats MDxHealth on 13 of the 15 factors compared between the two stocks. Get MDxHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for MDXH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MDXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDXH vs. The Competition Export to ExcelMetricMDxHealthMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$130.04M$2.00B$5.48B$9.57BDividend YieldN/AN/A3.99%4.17%P/E Ratio-3.0734.4029.9425.14Price / Sales1.3549.00398.9486.71Price / CashN/A50.3435.9458.58Price / Book8.719.088.105.59Net Income-$38.07M-$63.67M$3.26B$265.48M7 Day Performance11.11%1.36%0.68%1.22%1 Month Performance23.85%-0.62%2.46%0.39%1 Year Performance6.72%19.27%27.69%23.47% MDxHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDXHMDxHealth2.2717 of 5 stars$2.70-1.8%$7.00+159.3%+6.3%$130.04M$94.51M-3.07300Earnings ReportTALKTalkspace3.6842 of 5 stars$2.36+2.2%$4.50+90.7%+46.2%$386.50M$187.59M118.06500Earnings ReportAnalyst RevisionBFLYButterfly Network2.3857 of 5 stars$1.43+1.8%$3.50+145.6%+50.0%$346.20M$82.06M-5.09460Earnings ReportTBRGTruBridge1.8179 of 5 stars$21.22+3.3%$21.25+0.1%+115.6%$308.57M$345.74M-15.723,200News CoveragePositive NewsOMOutset Medical1.8425 of 5 stars$14.16-5.9%$29.50+108.3%-72.2%$266.54M$113.69M-0.49520News CoverageAnalyst ForecastGap UpNYXHNyxoah2.5905 of 5 stars$7.49+2.6%$14.50+93.6%-9.0%$248.64M$4.89M-3.52110Positive NewsHCATHealth Catalyst3.996 of 5 stars$3.63+3.1%$8.00+120.4%-32.7%$245M$306.58M-3.161,500News CoverageSOPHSOPHiA GENETICS2.0672 of 5 stars$3.30+4.4%$7.00+112.1%-12.3%$210.73M$65.17M-3.30520News CoverageEarnings ReportShort Interest ↑Gap UpHigh Trading VolumeZEPPZepp Health1.0576 of 5 stars$17.42+34.0%$13.87-20.4%+970.7%$188.49M$182.60M-3.471,230KRMDKORU Medical Systems1.9155 of 5 stars$3.38-2.9%$4.63+36.8%+81.7%$160.57M$33.65M-30.7380News CoverageEarnings ReportGap UpEUDAEUDA Health1.2231 of 5 stars$3.03-4.1%N/A-26.5%$117.60M$4.01M0.002News CoveragePositive NewsGap Down Related Companies and Tools Related Companies TALK Competitors BFLY Competitors TBRG Competitors OM Competitors NYXH Competitors HCAT Competitors SOPH Competitors ZEPP Competitors KRMD Competitors EUDA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MDXH) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MDxHealth SA Please log in to your account or sign up in order to add this asset to your watchlist. Share MDxHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
